CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO
CMP Therapeutics (CMPT) announced the appointment of Dr Neill Moray Mackenzie to the role of Chief Executive Officer. Dr Mackenzie brings to CMPT a long record of executive board level management within the biotechnology and pharmaceutical industries at companies including Cambridge genetics Ltd, Oxford Biomedica plc, Avidex Ltd (now Immunocore) and most recently as the SVP for business development and Corporate Strategy at Medigene AG and CEO of Roji Ltd (London). In addition, Dr MacKenzie was formerly a Departmental Head in Vaccine R&D at Wellcome and a Wellcome Lecturer in immunology at the University of London.
CMPT also announced the injection of a €1.5million convertible loan from Inventages Venture Capital to support continuing operations and the upcoming clinical trial of its lead product for the common cold. CMPT has been supported solely by investments from London-based Inventages Venture Capital and New Zealand-based BioPacificVentures since 2005.
Dr Bruce Savage, the former CEO, leaves CMPT to concentrate on his other portfolio companies.
Topics
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
ZEISS continues to advance digitalization of eye care - Acquisition of Veracity Innovations, LLC
Mayo Clinic finds new genetic cause of neurodegeneration

Microbial fuel cell converts methane to electricity
Radiotherapy can cause lasting vascular disease
